£121.80

This is the most expensive it has ever been. Walk away.

£122 today · previous high £122 · all-time low £122

Springer Cervix Cancer: 31 (Cancer Treatment and Research, 31)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 55 days · 55 data points (no recent data)

Historical
Generating forecast…
£121.80 £121.72 £121.74 £121.76 £121.77 £121.79 £121.81 23 July 2026 05 August 2026 19 August 2026 01 September 2026 15 September 2026
View at Amazon ↗

Price data last checked 36 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 55 days • 1 price levels

Days at Price
55 days 0 14 28 41 55 £122 Days at Price

Price Analysis

Most common price: £122 (55 days, 100.0%)

Price range: £122 - £122

Price levels: 1 different prices over 55 days

Description

Cytological screening for the identification of intraepithelial neoplasia of the cervix as a precursor lesion for cervical cancer has been well established as an effective means for decreasing the incidence of invasive carcinoma. Despite these screening efforts, carcinoma of the cervix remains one of the more common malignancies in women and it is the leading cause of cancer death in many countries in the western hemisphere. It is estimated that in 1986 there will still be 14,000 new cases of invasive cancer, with 6,800 deaths in the United States alone. Unfortunately, many of these patients present with advanced disease, posing difficult management problems for the clinician responsible for their care. The treatment of early stage invasive carcinoma of the cervix (lesions confined to the cervix and vagina) remains either radical surgery, radical radiation therapy or a combination thereof This approach is extraordinarily effective in the vast majority of patients. However, there remains a subset of patients with early stage disease that are at high risk for recurrence. Dr Kjorstad (Chapter 2) has identified adenocarcinomas and adenosqua mous carcinomas as having a particularly poor prognosis. In addition, patients with more than three positive lymph nodes or with involvement of lymph nodes outside of the pelvis have a very poor prognosis. He has iden tified the CEA as a potentially predictive marker for these patients with poor prognosis, especially in patients with adenocarcinomas.

Key Features

Used Book in Good Condition

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 March 1987
Listed Since
15 December 2006

Barcode

No barcode data available

Similar Products You Might Like

Cervical Cancer: 70 (Current Topics in Pathology, 70)
87% match

Cervical Cancer: 70 (Current Topics in Pathology, 70)

Springer

£76.42 01 Sep 2026
Trends in Cervical Cancer
86% match

Trends in Cervical Cancer

£33.28 31 Aug 2026
Preinvasive Carcinoma of the Cervix: Theory and Practice
86% match

Preinvasive Carcinoma of the Cervix: Theory and Practice

Springer

£71.99 16 Sep 2026
Colposcopy of Female Genital Tract
85% match

Colposcopy of Female Genital Tract

Springer

£86.01 08 Aug 2026
Therapie des Zervixkarzinoms
84% match

Therapie des Zervixkarzinoms

Springer

£60.40 16 Sep 2026
CD34 antigen and the stroma of uterine cervix: A clinicopathological study of role of CD34 antigen expressions in premalignant and malignant lesions of uterine cervix
83% match

CD34 antigen and the stroma of uterine cervix: A clinicopathological study of role of CD34 antigen expressions in premalignant and malignant lesions of uterine cervix

LAP Lambert Academic Publishing

£61.00 14 Sep 2026
Cervical Cancer: From Etiology to Prevention: 2 (Cancer Prevention-Cancer Causes, 2)
83% match

Cervical Cancer: From Etiology to Prevention: 2 (Cancer Prevention-Cancer Causes, 2)

Springer

£147.03 08 Aug 2026
Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)
82% match

Head and Neck Cancer: 114 (Cancer Treatment and Research, 114)

Springer

£114.71 07 Aug 2026
Cervical Cancer
82% match

Cervical Cancer

LAP Lambert Academic Publishing

£61.00 15 Sep 2026
Cervical Cancer: Contemporary Management
82% match

Cervical Cancer: Contemporary Management

Jaypee Brothers Medical Publishers

£59.26 14 Sep 2026
EARLY PATHOLOGIC DIAGNOSIS OF GYNECOLOGIC CANCER INCLUDING A CLINICIAN'S VIEW
82% match

EARLY PATHOLOGIC DIAGNOSIS OF GYNECOLOGIC CANCER INCLUDING A CLINICIAN'S VIEW

Scientific Publishing

£65.51 16 Oct 2026
Rare and Uncommon Gynecological Cancers: A Clinical Guide
82% match

Rare and Uncommon Gynecological Cancers: A Clinical Guide

Springer

£129.99 30 Aug 2026
New Developments in Cervical Cancer Screening and Prevention
81% match

New Developments in Cervical Cancer Screening and Prevention

Wiley

Price unavailable
HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)
81% match

HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)

Springer

£95.74 15 Sep 2026
HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)
81% match

HPV Infection in Head and Neck Cancer: 206 (Recent Results in Cancer Research, 206)

Springer

£73.10 06 Aug 2026
Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)
81% match

Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)

Springer

£71.08 20 Oct 2026
Cervical Cancer: Methods and Protocols: 1249 (Methods in Molecular Biology, 1249)
81% match

Cervical Cancer: Methods and Protocols: 1249 (Methods in Molecular Biology, 1249)

Humana

£54.38 31 Aug 2026
Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)
80% match

Head and Neck Oncology: 22 (Cancer Treatment and Research, 22)

Springer

£149.05 05 Aug 2026
HPV and Cervical Cancer: Achievements in Prevention and Future Prospects
80% match

HPV and Cervical Cancer: Achievements in Prevention and Future Prospects

Springer

£108.01 06 Aug 2026
Uncommon Gynecologic Cancers
80% match

Uncommon Gynecologic Cancers

Wiley

£101.92 04 Aug 2026
Oral Cancer: Diagnosis and Therapy
80% match

Oral Cancer: Diagnosis and Therapy

Springer

£94.63 21 Oct 2026
The Papillomaviruses
80% match

The Papillomaviruses

Springer

£108.01 08 Aug 2026
Uterine Cancer: Screening, Diagnosis, and Treatment (Current Clinical Oncology)
80% match

Uterine Cancer: Screening, Diagnosis, and Treatment (Current Clinical Oncology)

Springer

£80.67 15 Oct 2026
Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management
80% match

Gynecologic Radiation Therapy: Novel Approaches to Image-Guidance and Management

Springer

£88.21 08 Aug 2026